X1-FFR 991
X1-FFR 991 is a medical device (FDA Class II) made by Spectrawave, Inc., cleared under FDA 510(k) K251355 on 17 Oct 2025 and listed in FDA GUDID since 7 May 2026 (UDI-DI 00860008045539), active as of 2 Nov 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00860008045539 | Date7 May 2026 | StatusListed |
| United States | FDA 510(k)SESE | NumberK251355 | Date17 Oct 2025 | StatusActive |
Official records
- AccessGUDID record 00860008045539
- FDA 510(k) database K251355
From the FDA record
- Device description
- The SpectraWAVE X1-FFR Software is a standalone medical device which is used in the catheterization lab as an angiography image assessment tool for assessing Fractional Flow Reserve using non-invasive quantitative and functional analysis of coronary vasculature. The SpectraWAVE X1-FFR software comprises image processing and computational algorithms to perform functional coronary angiography, providing longitudinal estimations of coronary pressure drop and Fractional Flow Reserve (FFR) during angiogram and percutaneous coronary intervention (PCI) procedures. The SpectraWAVE X1-FFR Software is a procedural aid intended to be used to support diagnosis by clinicians. AI-derived algorithms are deployed on the device to support vessel segmentation and contouring. Analytical (non-AI) models are used for generating FFR values. The SpectraWAVE X1-FFR Software • provides measurements of localized coronary pressure drops over the length of a coronary vessel, including the right and left coronary tree. • provides dimensions of the coronary vessels and the amount of stenosis in coronary vessels; • enables physiology assessment in a non-invasive manner, without the need for adenosine and without the need for additional radiation and contrast administration.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K251355 decided 17 Oct 2025 Active
- FDA GUDID UDI-DI 00860008045539 listed 7 May 2026 Listed
Timeline
- Cleared FDA 510(k) K251355
- Listed FDA GUDID 00860008045539
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- X1-Ffr
- Generic name
- Diagnostic x-ray digital imaging system workstation
- Model / reference
- 991
- Primary DI / UDI-DI
- 00860008045539
- FDA product code
- QHA, LLZ
- GMDN term
- Diagnostic x-ray digital imaging system workstation
- Device class
- Class II
- Regulation number
- 892.1600, 892.2050
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code QHA (X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device).